Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non-small Cell Lung Cancer.
Malene Støchkel FrankChristina S A AndersenLise B AhlbornNiels PallisgaardUffe BødtgerJulie GehlPublished in: Cancer research communications (2022)
Treatment monitoring by ctDNA has the clinical potential to reveal PD before radiologic evaluation and consequently spare patients with advanced cancer from likely ineffective, costly cancer treatments and adverse events.